glabrata are regarded as intrinsically resistant species against azole antifungals
We aimed to define a risk stratification parameter to guide a comprehensive diagnostic approach, helping the decision to start antifungal
therapy in high-risk neutropenic patients.
Ian Nicholson, F2G's CEO commented: “F901318 is a significant addition to the antifungal
armamentarium as there have not been any new classes of antifungal
agents s approved for many years and growing resistance presents a considerable challenge in this seriously ill patient population.
Recurrent or persistent candidemia in patients on antifungal
therapy is suggestive of an infected intravascular device, significant immunosuppression, or antifungal
The echinocandins, first novel class of antifungals
in two decades: will they live up to their promise?
Hence, it seems reasonable to assume that most of the azole antifungals
used in agriculture and medicine as well as azoles used in management of breast cancer also act as inhibitors on human sterol 14[alpha]-demethylase to an unknown extent.
One in four women using over-the-counter antifungal
infection medications doesn't have a yeast infection, Dr.
The number of treatments is large and varied: frequent diaper changes, airing out the area by eliminating diapers whenever possible, super-absorbent diapers, disposable diapers, applying barrier creams and ointments, using corticosteroid creams, and topical antifungal
agents when Candida albicans fungal infections.
Objective: To determine Candida colonisation/infection in renal transplant patients and to determine the resistance pattern against antifungal
com)-- F2G Limited, the UK based antifungal
drug discovery and development company, today announced the appointment of Dr Michael R.
SAN DIEGO -- AIDS patients treated for cryptococcosis can safely stop their maintenance antifungal
therapy once they have reconstituted their immune systems using antiretroviral drugs, results of a French study suggest.
In an open-label trial of 69 immunocompromised patients aged 18-80 years with invasive aspergillosis who were refractory to or intolerant of other antifungals
, 41% (26) of the 63 patients who received at least one dose of Cancidas had complete resolution or clinically meaningful improvement.